DLA Piper LLP (US)
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
The described invention provides methods for targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis.
Board of Regents of the University of Texas System
G A C A A A G C A C A C A A C G C C A
G01N A61K C07D A61K A61K A61K G01N C07D A61K C07D A61K C07D A61K A61K C07D G01N C07D C07D A61K
additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Wentian Deepak Jerry W. Jef Pano
Wang Nijhawan Shay De Brabander Theodoropoulos